Přejít k obsahu
Merck

Potentiation of the anthelmintic activity of oxfendazole by parbendazole.

Journal of veterinary pharmacology and therapeutics (1985-09-01)
D R Hennessy, E Lacey, R K Prichard, J W Steel
ANOTACE

The ability of parbendazole (PBZ) to potentiate co-administered oxfendazole (OFZ) was investigated. Administration of a range (1.35-36.0 mg/kg) of doses of PBZ with 4.53 mg OFZ/kg demonstrated that significant potentiation occurred at 4.5 mg PBZ/kg. At 4.5 mg PBZ/kg, the area under the plasma OFZ concentration curve was about twice that obtained from oral administration of OFZ alone. When tested against benzimidazole-resistant Haemonchus contortus and Trichostrongylus colubriformis, the mixture of 4.5 mg PBZ + 4.53 mg OFZ/kg was significantly more effective than 4.53 mg OFZ/kg alone, and PBZ alone showed no activity against these resistant nematodes. The demonstration of PBZ-OFZ potentiation has indicated a means of obtaining a more effective use of currently available anthelmintics in the treatment of helminthiasis.

MATERIÁLY
Číslo produktu
Značka
Popis produktu

Supelco
Parbendazole, VETRANAL®, analytical standard